4-benzyl-3-crotonyl-2-oxazolidinone has been researched along with Acute Liver Injury, Drug-Induced in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, F; Huang, Q; Lin, X; Lu, C; Lu, S; Nie, J; Zhu, X; Zhuo, L | 1 |
1 other study(ies) available for 4-benzyl-3-crotonyl-2-oxazolidinone and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Didymin ameliorates hepatic injury through inhibition of MAPK and NF-κB pathways by up-regulating RKIP expression.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytokines; Flavonoids; Glycosides; Humans; Inflammation Mediators; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Origanum; Oxazolidinones; Phosphatidylethanolamine Binding Protein; RAW 264.7 Cells; Reactive Oxygen Species | 2017 |